Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells

Oncotarget
Francesca PunzoFrancesca Rossi

Abstract

Tumor-associated macrophages and their alternative activation states together with cytokines and growth factors trapped in tumor microenvironment contribute to the progression of OS. In contrast to other tumor types, M2 polarized macrophages, reduce metastasis and improve survival in osteosarcoma patients. Mifamurtide is an immunomodulatory drug given together with standard adjuvant chemotherapy in high-grade osteosarcoma to improve outcome. Macrophages obtained from peripheral blood mononucleated cells of healthy donors and MG63 cells were cultured alone and together, and treated with Mifamurtide. We analyzed the effects of Mifamurtide on macrophage polarization and on MG63 proliferation, migration and differentiation, evaluating the expression of M1/M2 and osteoblast markers and molecules involved in metastasis and proliferation pathways. Our data suggest that Mifamurtide, switching macrophage polarization towards a TAM-like intermediate M1/M2 phenotype, may modulate the delicate balance between pro-inflammatory and immunomodulatory macrophage functions. Moreover, Mifamurtide may inhibit the cellular proliferation and induce the tumor cell differentiation, probably through the down regulation of pSTAT3, pAKT and IL-17R.

References

Aug 6, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alison A BeharkaLarry S Schlesinger
May 4, 2007·The Journal of Clinical Investigation·Antonio Sica, Vincenzo Bronte
Aug 11, 2007·Journal of Cancer Research and Clinical Oncology·Maria Cristina HonoratiAndrea Facchini
Jul 16, 2008·The Journal of Biological Chemistry·Nadiya M TeplyukAndre J van Wijnen
Jan 14, 2011·Expert Opinion on Pharmacotherapy·Kosei AndoDominique Heymann
Mar 28, 2012·Autoimmunity Reviews·Stefania RecalcatiGaetano Cairo
Nov 30, 2012·Cancer Biology & Therapy·Mingmin WangZhenke Wen
Nov 28, 2013·Nature Communications·Vanessa BylesTiffany Horng
Mar 29, 2014·F1000prime Reports·Fernando O Martinez, Siamon Gordon
Jun 14, 2014·Advances in Experimental Medicine and Biology·Paul A Meyers, Alexander J Chou
Nov 5, 2014·Frontiers in Immunology·Paola Italiani, Diana Boraschi
Dec 17, 2014·Frontiers in Immunology·Nan WangKe Zen
Mar 5, 2015·Anti-cancer Agents in Medicinal Chemistry·Na LiQiping Zheng
Sep 12, 2015·Seminars in Immunology·Anthony J CovarrubiasTiffany Horng
Nov 29, 2015·The Orthopedic Clinics of North America·Megan E Anderson
Mar 12, 2016·Mediators of Inflammation·Jaehong Kim, Jong-Sup Bae
May 21, 2016·Anti-cancer Agents in Medicinal Chemistry·Jie ZhuWei Li
Aug 25, 2016·Journal of Bone Oncology·Daniel BranstetterWilliam C Dougall
Nov 23, 2016·Clinical Spine Surgery : a Spine Publication·Naresh KumarEmily Stone
Dec 21, 2016·Current Cancer Drug Targets·Giulia BelliniFrancesca Rossi
Jan 25, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eleni VergadiChristos Tsatsanis
Mar 1, 2017·Journal of Hematology & Oncology·Li Yang, Yi Zhang
Apr 7, 2017·Journal of Cancer·Maonan WangCan Guo
May 4, 2017·The Journal of Pathology·Emanuele CenciniMonica Bocchia
May 26, 2017·Current Opinion in Pharmacology·Nathalie DehneBernhard Brüne
Dec 16, 2017·Trends in Cell Biology·Shuan RaoJosef M Penninger
Jun 12, 2018·Journal of Pediatric Hematology/oncology·Nurdan TacyildizGulsan Yavuz
Jul 29, 2018·Free Radical Biology & Medicine·Izumi Yanatori, Fumio Kishi
Jan 22, 2019·Critical Reviews in Oncology/hematology·Peter A van DamMartin Lammens
Mar 12, 2019·Frontiers in Immunology·David EiselStefan B Eichmüller
May 18, 2019·Cell Death & Disease·Zhe GuoQi Wang
May 22, 2019·Asia-Pacific Journal of Clinical Oncology·Huayan TangJian Lu

❮ Previous
Next ❯

Citations

May 31, 2020·International Journal of Molecular Sciences·Francesca RossiFrancesca Punzo
Jul 29, 2020·International Journal of Molecular Sciences·Francesca CersosimoEmanuele Giurisato
Nov 4, 2020·Tissue Engineering. Part B, Reviews·Thomas ChowClaudia Di Bella
Dec 29, 2020·Frontiers in Oncology·Zhong-Wei LuoHui Xie
Dec 31, 2020·International Journal of Molecular Sciences·Alessandra Di PaolaFrancesca Rossi
Apr 1, 2021·Cellular Oncology (Dordrecht)·Qingshan HuangWei Guo

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
Assay

Software Mentioned

Image studio Digits
Primer
Muse

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

JBI Database of Systematic Reviews and Implementation Reports
Rincy JimmySarahlouise White
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Max BrosaLaia Cubells
© 2021 Meta ULC. All rights reserved